SEELOS THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Seelos Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Seelos Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 6, 2024 was 5.96M shares, a 95.3% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 5.96M -121M -95.3% Aug 6, 2024 10-Q 2024-08-14
Q1 2024 16.6M -105M -86.4% Apr 26, 2024 10-K/A 2024-04-29
Q3 2023 161M +54.2M +50.6% Nov 6, 2023 10-Q 2023-11-14
Q2 2023 127M +20.7M +19.4% Aug 4, 2023 10-Q 2023-08-11
Q1 2023 122M +16.3M +15.5% May 5, 2023 10-Q 2023-05-12
Q3 2022 107M +4.78M +4.67% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 107M +4.38M +4.28% Jul 25, 2022 10-Q 2022-08-05
Q1 2022 106M +26.9M +34.3% Mar 4, 2022 10-K 2022-03-04
Q3 2021 102M +49M +91.7% Oct 29, 2021 10-Q 2021-11-05
Q2 2021 102M +57.9M +130% Jul 29, 2021 10-Q 2021-08-06
Q1 2021 78.6M +33.6M +74.8% Apr 22, 2021 10-Q 2021-04-30
Q3 2020 53.4M +26.5M +98.2% Nov 6, 2020 10-Q 2020-11-12
Q2 2020 44.4M +21.9M +97.6% Aug 6, 2020 10-Q 2020-08-14
Q1 2020 44.9M +26.5M +144% May 1, 2020 10-Q 2020-05-07
Q3 2019 26.9M -1.22M -4.32% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 22.5M -967K -4.12% Jul 25, 2019 10-Q 2019-08-01
Q1 2019 18.4M -5.04M -21.5% Mar 14, 2019 10-K 2019-03-28
Q3 2018 28.2M +13M +85.1% Oct 29, 2018 10-Q 2018-10-31
Q2 2018 23.4M +10.7M +83.4% Aug 6, 2018 10-Q 2018-08-09
Q1 2018 23.4M +15.7M +203% Apr 27, 2018 10-Q 2018-05-03
Q3 2017 15.2M +7.48M +96.8% Oct 27, 2017 10-Q 2017-11-02
Q2 2017 12.8M -34.3M -72.9% Jul 28, 2017 10-Q 2017-08-02
Q1 2017 7.74M -54M -87.5% Mar 7, 2017 10-K 2017-03-13
Q3 2016 7.73M -42.7M -84.7% Oct 31, 2016 10-Q 2016-11-08
Q2 2016 47.1M -3.31M -6.57% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 61.8M +11.4M +22.5% Mar 3, 2016 10-K 2016-03-09
Q3 2015 50.4M +6.79M +15.6% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 50.4M +12.3M +32.3% Jul 30, 2015 10-Q 2015-08-05
Q1 2015 50.4M +12.5M +33.1% Mar 11, 2015 10-K 2015-03-16
Q3 2014 43.6M +6.09M +16.2% Nov 6, 2014 10-Q 2014-11-10
Q2 2014 38.1M +1.12M +3.03% Aug 7, 2014 10-Q 2014-08-11
Q1 2014 37.9M +7.53M +24.8% Mar 13, 2014 10-K 2014-03-17
Q3 2013 37.5M +7.63M +25.5% Nov 8, 2013 10-Q 2013-11-12
Q2 2013 37M +7.39M +25% Aug 12, 2013 10-Q 2013-08-14
Q1 2013 30.3M +3.82M +14.4% Mar 11, 2013 10-K 2013-03-18
Q3 2012 29.9M +8.94M +42.6% Nov 1, 2012 10-Q 2012-11-08
Q2 2012 29.6M +9.57M +47.8% Aug 2, 2012 10-Q 2012-08-09
Q1 2012 26.5M Mar 8, 2012 10-K 2012-03-13
Q3 2011 21M Nov 9, 2011 10-Q 2011-11-14
Q2 2011 20M Aug 9, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.